UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial

European heart journal, 2013-10, Vol.34 (40), p.3137-3144

2013

Link zum Volltext

Verfügbarkeit prüfen

Erratum. Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Diabetes Care 2020;44:2853-2858

Diabetes care, 2022-10, Vol.45 (10), p.2476-2476

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population

Diabetes care, 2020-11, Vol.43 (11), p.2853-2858

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk factor reduction in type 2 diabetes demands a multifactorial approach

European journal of preventive cardiology, 2019-12, Vol.26 (2_suppl), p.81-91

2019

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

European heart journal, 2024-04, Vol.45 (15), p.1371-1374

2024

Link zum Volltext

Verfügbarkeit prüfen

Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis

Diabetes care, 2022-10, Vol.45 (10), p.e146-e147

2022

Link zum Volltext

Verfügbarkeit prüfen

High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors

Diabetes care, 2024-02, Vol.47 (2), p.246

2024

Link zum Volltext

Verfügbarkeit prüfen

Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population

Cardiovascular diabetology, 2024-01, Vol.23 (1), p.18-18, Article 18

2024

Link zum Volltext

Verfügbarkeit prüfen

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial

European heart journal, 2008-01, Vol.29 (2), p.166-176

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

Cardiovascular diabetology, 2023-08, Vol.22 (1), p.1-220, Article 220

2023

Link zum Volltext

Verfügbarkeit prüfen

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

Cardiovascular diabetology, 2022-07, Vol.21 (1), p.1-129, Article 129

2022

Link zum Volltext

Verfügbarkeit prüfen

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design

International journal of cardiology, 2020-08, Vol.313, p.76-82

2020

Link zum Volltext

Verfügbarkeit prüfen

Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial

Diabetes care, 2012-04, Vol.35 (4), p.911-917

2012

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states

Cardiovascular diabetology, 2024-01, Vol.23 (1), p.25-25, Article 25

2024

Link zum Volltext

Verfügbarkeit prüfen

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry

Diabetes research and clinical practice, 2022-01, Vol.183, p.109156-109156

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory bowel disease and cardiovascular diseases: a concise review

European heart journal open, 2022-01, Vol.2 (1), p.oeab029-oeab029

2022

Link zum Volltext

Verfügbarkeit prüfen

Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study

Cardiovascular diabetology, 2022-09, Vol.21 (1), p.1-195, Article 195

2022

Link zum Volltext

Verfügbarkeit prüfen

Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial

European journal of heart failure, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG

Clinical therapeutics, 2016-06, Vol.38 (6), p.1279-1287

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of dipeptidyl peptidase‐4 inhibitors on complement activation

Diabetes/metabolism research and reviews, 2021-03, Vol.37 (3), p.e3385-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

Cardiovascular diabetology, 2021-02, Vol.20 (1), p.38-38, Article 38

2021

Link zum Volltext

Verfügbarkeit prüfen

Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study

Cardiology research and practice, 2023-12, Vol.2023, p.6687803-9

2023

Link zum Volltext

Verfügbarkeit prüfen

Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial

European journal of preventive cardiology, 2019-05, Vol.26 (8), p.847-854

2019

Link zum Volltext

Verfügbarkeit prüfen

Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide

European heart journal open, 2024-01, Vol.4 (1), p.oead130-oead130

2024

Link zum Volltext

Verfügbarkeit prüfen

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial

European heart journal, 2013-02, Vol.34 (5), p.374-379

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(129)
Dissertationen
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(97)
Science & Technology
(89)
Life Sciences & Biomedicine
(88)
Humans
(67)
Cardiovascular System & Cardiology
(57)
Risk Factors
(48)
Cardiac & Cardiovascular Systems
(43)
Endocrinology & Metabolism
(42)
Male
(41)
Female
(40)
Diabetes
(39)
Diabetes Mellitus
(35)
Aged
(33)
Cardiovascular Disease
(30)
Middle Aged
(30)
Myocardial Infarction
(28)
Prognosis
(28)
Diabetes Mellitus, Type 2 - Complications
(25)
Diabetes Mellitus, Type 2 - Drug Therapy
(25)
Type 2 Diabetes
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial

Erratum. Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Diabetes Care 2020;44:2853-2858

Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population

Risk factor reduction in type 2 diabetes demands a multifactorial approach

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis

High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors

Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial

Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design

Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial

Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry

Inflammatory bowel disease and cardiovascular diseases: a concise review

Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study

Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial

Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG

Effect of dipeptidyl peptidase‐4 inhibitors on complement activation

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study

Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial

Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial

Suchergebnisse filtern